| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.013 | 0.8 |
| mRNA | AEW541 | CCLE | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | -0.0054 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | BRD-K78574327 | CTRPv2 | pan-cancer | AAC | 0.35 | 2e-07 |
| mRNA | NSC95397 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | 0.14 | 3e-05 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | 0.15 | 5e-05 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.25 | 9e-05 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.0001 |